EN
HI
Summary
As of 15 Sep, 2026, Genpharmasec stock price is ₹1.13. During the trading session, the stock has moved between an intraday low of ₹1.13 and an intraday high of ₹1.21. Over the last 52 weeks, Genpharmasec has traded between ₹0.75 and ₹2.15.
The stock has recorded a trading volume of 2,70,928 shares,. Its Average Traded Price (ATP) is ₹1.14, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 5 @ ₹1.13.
Genpharmasec has an upper circuit limit of ₹1.40 and a lower circuit limit of ₹0.94. The total value traded stands at ₹3.09 L, and the delivery percentage for the day is 73.37%.
The stock is currently traded with a market lot size of 1. Genpharmasec also offers a dividend yield of 0%.
Genpharmasec Share Price Chart
Genpharmasec Share Key Metrics
Volume
2.71 L
Market Cap
62.57 CR
LTQ@LTP
5@1.13
ATP
1.14
Var Margin
25.37 %
Circuit Range
0.94-1.4
Delivery %
73.37 %
Value
3.09 L
ASM/GSM
No
Market Lot
1
Genpharmasec Fundamentals
P/E Ratio
0
P/B Ratio
0.98
Div. Yield
0
Sector P/E
63.17
Sector P/B
1.77
Sec. Div. Yield
75.4
Genpharmasec Resistance and Support
Pivot 1.17
Resistance
First Resistance
1.22
Second Resistance
1.27
Third Resistance
1.32
Support
First Support
1.12
Second Support
1.07
Third Support
1.02
Genpharmasec Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Tue Sep 15 2026 | 1.17 | 1.13 | -2.59% | 1.21 | 1.13 |
| Fri Sep 11 2026 | 1.15 | 1.16 | 0.87% | 1.22 | 1.12 |
| Thu Sep 10 2026 | 1.12 | 1.15 | 2.68% | 1.17 | 1.12 |
Genpharmasec Corporate Actions
| Date | Agenda |
|---|---|
| 2026-09-02 | Others |
| 2026-08-11 | Quarterly Results |
| 2026-05-21 | Audited Results |
| 2026-02-09 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-09-02 | Others |
| 2025-08-07 | Quarterly Results |
| 2025-05-21 | Audited Results |
| 2025-03-24 | Independent Director Meeting |
| 2025-02-10 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
Genpharmasec News
Genpharmasec Ltd - 531592 - Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Wednesday, 02Nd September, 2026.
Genpharmasec board approved the 34th Annual General Meeting (AGM) to be held on September 29, 2026, through video conferencing. The board also approved the Annual Report and Director's Report for FY26 and re-appointed Mr. Sohan Chaturvedi as Whole Time Director for a three-year term, subject to shareholder consent.
Sep 02 2026 15:49:07
Genpharmasec Ltd - 531592 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Genpharmasec's promoter, Rajesh Mirchumal Sadhwani, acquired 50 lakh equity shares through open market purchases on August 28, 2026. This transaction increased his individual stake by 0.91% to 14.09%.
Aug 31 2026 12:04:44
Read More
Genpharmasec Management
| Name | Position |
|---|---|
| Sohan Chaturvedi | Whole Time Director & Chief Financial Officer |
| Rajesh Sadhwani | Non Independent & Non Executive Director |
Genpharmasec Similar Stocks
Anand Rayons Ltd.
40.89
0.11 (0.27%)
Kabsons Industries Ltd.
20.25
0.00 (0.00%)
Sodhani Academy Of Fintech Enablers Ltd.
126.00
0.00 (0.00%)
Innovatus Entertainment Networks Ltd.
14.50
0.00 (0.00%)
Prospect Consumer Products Ltd.
38.19
1.19 (3.22%)
Ashnisha Industries Ltd.
2.34
-0.09 (3.70%)
Mohit Paper Mills Ltd.
26.01
-0.55 (2.07%)
Future Market Networks Ltd.
9.12
-0.48 (5.00%)
Bombay Cycle & Motor Agency Ltd.
1578.80
-20.10 (1.26%)
Genpharmasec FAQs
The Buying Price of Genpharmasec share is 1.13 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Genpharmasec stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Genpharmasec, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Genpharmasec shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Genpharmasec shares is 0.98. Useful to assess the stock's value relative to its book value.
To assess Genpharmasec’s valuation compare Sector P/E, P/B which are 63.17 & 1.77 with sector averages, along with growth rates and financial metrics.
The Market Cap of Genpharmasec is 62.57 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Genpharmasec share price is 2.15 & 0.75. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Genpharmasec belongs to the Miscellaneous sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in GENPHARMA
